We further measured autoantibodies against IFN-α2 and -ω before and after SARS-CoV-2 vaccination in 10 patients with APS-1, to investigate whether the interferon autoantibodies were affected by vaccination. Here, IFNA2 is linked to autoimmune polyendocrine syndrome type 1.